 | • レポートコード：GIR-22F19616 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Seasonal Affective Disorder Drugs Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の季節性情動障害治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 季節性情動障害治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・SSRI、SNRI、NDRI、TCA、MOAI アプリケーション別セグメントは次のように区分されます。 ・病院薬局、オンライン薬局、リテール薬局 世界の季節性情動障害治療薬市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer、GlaxoSmithKline、Bristol-Myers Squibb、Otsuka Pharmaceutical、Mylan、Merck 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、季節性情動障害治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な季節性情動障害治療薬メーカーの企業概要、2019年～2022年までの季節性情動障害治療薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な季節性情動障害治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別季節性情動障害治療薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの季節性情動障害治療薬のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での季節性情動障害治療薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および季節性情動障害治療薬の産業チェーンを掲載しています。 ・第13、14、15章では、季節性情動障害治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 季節性情動障害治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：SSRI、SNRI、NDRI、TCA、MOAI - アプリケーション別分析（2017年vs2021年vs2028年）：病院薬局、オンライン薬局、リテール薬局 - 世界の季節性情動障害治療薬市場規模・予測 - 世界の季節性情動障害治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、GlaxoSmithKline、Bristol-Myers Squibb、Otsuka Pharmaceutical、Mylan、Merck ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：SSRI、SNRI、NDRI、TCA、MOAI ・アプリケーション別分析2017年-2028年：病院薬局、オンライン薬局、リテール薬局 ・季節性情動障害治療薬の北米市場分析 - 季節性情動障害治療薬の北米市場：タイプ別市場規模2017年-2028年 - 季節性情動障害治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・季節性情動障害治療薬のヨーロッパ市場分析 - ：季節性情動障害治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：季節性情動障害治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・季節性情動障害治療薬のアジア太平洋市場分析 - 季節性情動障害治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 季節性情動障害治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・季節性情動障害治療薬の南米市場分析 - 季節性情動障害治療薬の南米市場：タイプ別市場規模2017年-2028年 - 季節性情動障害治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・季節性情動障害治療薬の中東・アフリカ市場分析 - 季節性情動障害治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 季節性情動障害治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Seasonal Affective Disorder Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Seasonal Affective Disorder Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Seasonal Affective Disorder Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While SSRIs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Seasonal Affective Disorder Drugs include Pfizer, GlaxoSmithKline, Bristol-Myers Squibb, Otsuka Pharmaceutical, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Seasonal Affective Disorder Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
SSRIs
SNRIs
NDRIs
TCAs
MOAIs
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The key market players for global Seasonal Affective Disorder Drugs market are listed below:
Pfizer
GlaxoSmithKline
Bristol-Myers Squibb
Otsuka Pharmaceutical
Mylan
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Seasonal Affective Disorder Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Seasonal Affective Disorder Drugs, with price, sales, revenue and global market share of Seasonal Affective Disorder Drugs from 2019 to 2022.
Chapter 3, the Seasonal Affective Disorder Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Seasonal Affective Disorder Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Seasonal Affective Disorder Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Seasonal Affective Disorder Drugs.
Chapter 13, 14, and 15, to describe Seasonal Affective Disorder Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Seasonal Affective Disorder Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Seasonal Affective Disorder Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 SSRIs
1.2.3 SNRIs
1.2.4 NDRIs
1.2.5 TCAs
1.2.6 MOAIs
1.3 Market Analysis by Application
1.3.1 Overview: Global Seasonal Affective Disorder Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Seasonal Affective Disorder Drugs Market Size & Forecast
1.4.1 Global Seasonal Affective Disorder Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Seasonal Affective Disorder Drugs Sales in Volume (2017-2028)
1.4.3 Global Seasonal Affective Disorder Drugs Price (2017-2028)
1.5 Global Seasonal Affective Disorder Drugs Production Capacity Analysis
1.5.1 Global Seasonal Affective Disorder Drugs Total Production Capacity (2017-2028)
1.5.2 Global Seasonal Affective Disorder Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Seasonal Affective Disorder Drugs Market Drivers
1.6.2 Seasonal Affective Disorder Drugs Market Restraints
1.6.3 Seasonal Affective Disorder Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Seasonal Affective Disorder Drugs Product and Services
2.1.4 Pfizer Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Seasonal Affective Disorder Drugs Product and Services
2.2.4 GlaxoSmithKline Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Seasonal Affective Disorder Drugs Product and Services
2.3.4 Bristol-Myers Squibb Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Otsuka Pharmaceutical
2.4.1 Otsuka Pharmaceutical Details
2.4.2 Otsuka Pharmaceutical Major Business
2.4.3 Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Product and Services
2.4.4 Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Seasonal Affective Disorder Drugs Product and Services
2.5.4 Mylan Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Seasonal Affective Disorder Drugs Product and Services
2.6.4 Merck Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Seasonal Affective Disorder Drugs Breakdown Data by Manufacturer
3.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Seasonal Affective Disorder Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Seasonal Affective Disorder Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Seasonal Affective Disorder Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Seasonal Affective Disorder Drugs Manufacturer Market Share in 2021
3.5 Global Seasonal Affective Disorder Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Seasonal Affective Disorder Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Seasonal Affective Disorder Drugs Market Size by Region
4.1.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Seasonal Affective Disorder Drugs Revenue by Region (2017-2028)
4.2 North America Seasonal Affective Disorder Drugs Revenue (2017-2028)
4.3 Europe Seasonal Affective Disorder Drugs Revenue (2017-2028)
4.4 Asia-Pacific Seasonal Affective Disorder Drugs Revenue (2017-2028)
4.5 South America Seasonal Affective Disorder Drugs Revenue (2017-2028)
4.6 Middle East and Africa Seasonal Affective Disorder Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Type (2017-2028)
5.2 Global Seasonal Affective Disorder Drugs Revenue by Type (2017-2028)
5.3 Global Seasonal Affective Disorder Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Application (2017-2028)
6.2 Global Seasonal Affective Disorder Drugs Revenue by Application (2017-2028)
6.3 Global Seasonal Affective Disorder Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
7.2 North America Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
7.3 North America Seasonal Affective Disorder Drugs Market Size by Country
7.3.1 North America Seasonal Affective Disorder Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Seasonal Affective Disorder Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
8.2 Europe Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
8.3 Europe Seasonal Affective Disorder Drugs Market Size by Country
8.3.1 Europe Seasonal Affective Disorder Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Seasonal Affective Disorder Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Seasonal Affective Disorder Drugs Market Size by Region
9.3.1 Asia-Pacific Seasonal Affective Disorder Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Seasonal Affective Disorder Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
10.2 South America Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
10.3 South America Seasonal Affective Disorder Drugs Market Size by Country
10.3.1 South America Seasonal Affective Disorder Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Seasonal Affective Disorder Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Seasonal Affective Disorder Drugs Market Size by Country
11.3.1 Middle East & Africa Seasonal Affective Disorder Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Seasonal Affective Disorder Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Seasonal Affective Disorder Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Seasonal Affective Disorder Drugs
12.3 Seasonal Affective Disorder Drugs Production Process
12.4 Seasonal Affective Disorder Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Seasonal Affective Disorder Drugs Typical Distributors
13.3 Seasonal Affective Disorder Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer